CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma

Published:2017-01-06 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Zhou Jin,Wu Zhong,Wong Gabrielle,Pectasides Eirini,Nagaraja Ankur,Stachler Matthew,Zhang Haikuo,Chen Ting,Zhang Haisheng,Liu Jie Bin,Xu Xinsen,Sicinska Ewa,Sanchez-Vega Francisco,Rustgi Anil K.,Diehl J. Alan,Wong Kwok-Kin,Bass Adam J.

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/ncomms13897.pdf

Reference42 articles.

1. Siegel, R., Naishadham, D. & Jemal, A. Cancer statictics, 2013. CA Cancer J. Clin. 63, 11–30 (2013).

2. Jemal, A., Siegel, R., Xu, J. & Ward, E. Cancer Statistics, 2010. CA Cancer J. Clin. 60, 277–300 (2010).

3. Rustgi, A. K. & El-Serag, H. B. Esophageal carcinoma. N. Engl. J. Med. 371, 2499–2509 (2014).

4. Gao, Y. et al. Genetic landscape of esophageal squamous cell carcinoma. Nat. Genet. 46, 1097–1105 (2014).

5. Hanawa, M. et al. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int. J. Cancer 118, 1173–1180 (2006).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specificity of U2 and GOL1 aptamers to EGFR-positive human glioblastoma cells in vitro;Журнал высшей нервной деятельности им. И.П. Павлова;2024-07-10

2. Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma;eBioMedicine;2024-07

3. Specificity of Aptamers U2 and Gol1 to EGFR-Positive Human Glioblastoma Cells in Vitro;Neuroscience and Behavioral Physiology;2024-07

4. CDK4/6 signaling attenuates the effect of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer;Translational Lung Cancer Research;2023-10

5. Expression and significance of cyclin D1, cyclin-dependent kinase 4 and cyclin-dependent kinase inhibitor P27 in patients with non-neoplastic epithelial disorders of the vulva;Experimental and Therapeutic Medicine;2023-06-02